0.8 ML sodium hyaluronate 12 MG/ML Prefilled Syringe [Amvisc]
RxNorm concept 1192860, branded drug (sbd). Prescribable name: Amvisc 1.2 % in 0.8 mL Prefilled Syringe.
- RxCUI
- 1192860
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1192860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.8 ML Amvisc 12 MG/ML Prefilled Syringe; Amvisc 1.2 % per 0.8 ML Prefilled Syringe
Related concepts
- sodium hyaluronate 12 MG/ML (SCDC, consists of)
- sodium hyaluronate 12 MG/ML [Amvisc] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Amvisc (BN, has ingredient)
- 0.8 ML sodium hyaluronate 12 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
- 57770049565
- 61772059081
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1192860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1192860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1192860. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.